Incyte 将于10月29日发布2026年第三季度财务业绩
Incyte to Report Third Quarter Financial Results
Incyte（Nasdaq:INCY）宣布将于2026年10月29日发布第三季度财务业绩，并于美东时间当日8:00举行电话会议和网络直播，新闻稿于7:00发布。电话会议回放将在会后30天内提供，网络直播及幻灯片可在Investor.Incyte.com回看90天。
WILMINGTON, Del.--(BUSINESS WIRE)--Oct. 8, 2026-- Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Thursday, October 29, 2026.
The schedule for the press release and conference call/webcast is as follows:
- Q3 2026 Press Release: October 29, 2026, at 7:00 a.m. ET
- Q3 2026 Conference Call: October 29, 2026, at 8:00 a.m. ET
- Domestic Dial-In Number: 877-407-3042
- International Dial-In Number: 201-389-0864
- Conference ID Number: 13763051
If you are unable to participate, a replay of the conference will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference identification number 13763051.
A live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.
About Incyte
Incyte is redefining what’s possible in biopharmaceutical innovation. Through deep scientific expertise and a relentless focus on patients, we have built an established portfolio of first-in-class medicines and an extensive portfolio of next-generation medicines across our key franchises: Hematology, Oncology and Inflammation & Autoimmunity.
To learn more, visit Incyte.com and Investor.Incyte.com. Follow us on social media: LinkedIn, X, and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261008696942/en/
Source: Incyte
来源：Incyte · investor.incyte.com